Clinical Trials
14 trialsNCT06303193 2026-05-27
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
NCT00027274 2026-05-22
Cancer in Inherited Bone Marrow Failure Syndromes
National Institutes of Health Clinical Center (CC)
Recruiting
NCT01351545 2026-04-13
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Center for International Blood and Marrow Transplant Research
Recruiting
NCT04645199 2026-02-12
NICHE
Institute of Hematology & Blood Diseases Hospital, China
Recruiting
NCT06430788 2025-12-17
A Study of Emapalumab for Pediatric Aplastic Anemia
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT05194397 2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2 Recruiting
NCT06689800 2025-12-02
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Washington University School of Medicine
Phase NA Recruiting
NCT05031897 2025-10-30
Two Step Haplo With Radiation Conditioning
Thomas Jefferson University
Phase 2 Recruiting
NCT01137643 2025-10-27
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
Recruiting
NCT03016806 2025-10-10
Umbilical Cord Blood Transplantation From Unrelated Donors
University of Rochester
Recruiting
NCT07205523 2025-10-03
HALO-SCT
Affiliated Hospital of Qinghai University
Recruiting
NCT06398457 2025-09-26
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Recruiting
NCT07145411 2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
NCT04099966 2025-08-08
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
New York Medical College
Phase 2 Recruiting